These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Beneficial effect of time-restricted eating on blood pressure: a systematic meta-analysis and meta-regression analysis.
    Author: Wang W, Wei R, Pan Q, Guo L.
    Journal: Nutr Metab (Lond); 2022 Nov 08; 19(1):77. PubMed ID: 36348493.
    Abstract:
    BACKGROUND: As a cardiometabolic disease, hypertension has shown an obvious upward trend, becoming a global epidemic chronic disease. Lifestyle intervention is a fundamental method for lowering blood pressure. This systematic review and meta-analysis aimed to evaluate the effects of time-restricted eating (TRE) on blood pressure. METHODS: Studies were retrieved from the PubMed, Embase, Cochrane Library, and Web of Science databases to evaluate the effects of TRE on blood pressure. The time frame of search was from the start of database construction until July 14, 2022.There were no language restrictions. Meta-analysis and meta-regression were performed using Stata version 16. The weighted mean difference with 95% CI was used to assess the effect of TRE on blood pressure, heart rate, weight, blood glucose, total cholesterol, HDL-C, LDL-C, and triglycerides. The main ending of this article were blood pressure and heart rate, while the secondary ending were weight, blood glucose, total cholesterol, HDL-C, LDL-C, and triglycerides. RESULTS: Ten randomized controlled trials involving 694 patients were identified. TRE significantly reduced systolic blood pressure (SBP) (mean difference = -4.15; 95% CI: -6.73, -2.30; P < 0.0001), but had no significant effect on diastolic blood pressure (DBP) (mean difference = -2.06; 95% CI: -4.16, 0.02; P = 0.053) and no beneficial effect on heart rate (mean difference = 0.36; 95% CI: -2.83, 3.54; P = 0.0825). TRE promoted weight loss (mean difference = -1.63; 95% CI: -2.61, -0.64; P = 0.001) and decreased blood glucose levels (mean difference = -2.80; 95% CI: -4.64, -0.96; P = 0.003), but had no significant effect on total cholesterol (mean difference = 0.03, 95% CI: -10.01, 10.08; P = 0.995), HDL-C (mean difference = 0.85, 95% CI: -1.80, 3.49; P = 0.531), LDL-C (mean difference = -0.86, 95% CI: -6.47, 4.76; P = 0.764), or triglycerides (mean difference = -3.524, 95% CI: -9.49, 2.45; P = 0.248). In a separate meta-regression analysis, the degree of SBP change was related to weight loss (P = 0.044) but not to glucose improvement (P = 0.867). CONCLUSIONS: The present meta-analysis suggests that TRE significantly reduced SBP, while no effect of reducing DBP was seen. The observed lower blood pressure may be attributed to significant weight loss. The effects of TRE on heart rate and blood lipid levels were not apparent.
    [Abstract] [Full Text] [Related] [New Search]